PFE stock analysis: Q4 $17.6B rev beat, FY26 $59.5-62.5B guide, obesity pipeline. Is PFE stock a buy? March 2, 2026 data.
Introduction
Pfizer makes drugs, vaccines like Comirnaty. PFE stock draws dividend hunters post-COVID. Pharma faces tariffs, LOEs.[code_file:PFE_quotes_e664e3.csv]
PFE stock price rises.
Latest Stock Price & Trend
PFE $27.65, up 2.03% ($0.55). Day range $27.09-$27.66; volume 30M under 48M avg.[code_file:PFE_quotes_e664e3.csv]
YTD -7%; 52-week $21-$28. Sideways base.
Value play.[code_file:PFE_price_history_2024-01-01_2025-07-14_1day_4ed82c.csv]
Technical Analysis
Support $27, $26 firm. Resistance $28, $29.
RSI neutral. MACD flat.
50-day nears 200-day. Volume low.
Stable range.
Analyst Ratings & Price Targets
Hold bias. Avg $30; high $40, low $25.
Dividend focus.
Insider Activity
Sahni Feb options routine.[code_file:PFE_insider_transactions.csv]
Awards steady. Cautious.
Valuation Analysis
Trailing P/E 20; EPS $1.36.[code_file:PFE_quotes_e664e3.csv] P/S 2.5x.
FY25 $62.6B flat. Cash ample.
Undervalued vs. peers.
Recent Earnings & Catalysts
Q4 2025 rev $17.6B beat; EPS $0.66.
FY26 $59.5-62.5B. Catalysts: Vesper obesity, Seagen oncology.
Mild reaction.
Bullish Case
Vyndaqel +7%. Cost $7.7B save.
Pipeline obesity. Dividend grow.
Bearish Case
COVID drop 40%. LOE $1.5B.
Tariffs hit. Generic pressure.
Market Sentiment & Investor Psychology
Institutions hold: Vanguard 541M.[code_file:PFE_institutional_holders.csv]
Value neutral.
Short-Term Outlook
Hold range.
Medium to Long-Term Outlook
Stable cash cow. Accumulate.
FAQ
Is PFE Stock a Buy Right Now?
Dividend yes.
What Is the Price Target for PFE Stock?
$30 avg.
What Are Major Risks for PFE Stock?
LOEs ahead.
PFE Earnings Outlook?
Suggestions
Compare with Opendoor
See pharma forecast.
Read dividend stocks.
Final Balanced Conclusion
Buy. Cheap yield, pipeline offset.
Disclaimer: This article is for informational purposes only and not financial advice.